Literature DB >> 2585690

Doctors, drug companies, and gifts.

M M Chren1, C S Landefeld, T H Murray.   

Abstract

Doctors often accept gifts from drug companies. We analyze this practice and conclude that accepting a gift has complex practical and ethical repercussions. Gifts cost patients money, and they may change society's perception of the profession as serving the best interest of patients. Also, accepting a gift establishes a relationship between the physician and the drug company that obliges a response from the physician. Accepting gifts and the resulting relationship have ethical implications as well. First, the use of patients' money to pay for gifts can be unjust. Second, the fiduciary relationship between physician and patient may be threatened if prescribing practices are affected (as intended by the drug company). Third, physicians' characters may be altered by a practice that fosters self-interest at patients' expense. We discuss the need for guidelines for the profession to help physicians promote their patients' well-being.

Entities:  

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  1989        PMID: 2585690

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  35 in total

1.  Pharmaceutical advertising revenue and physician organizations: how much is too much?

Authors:  P A Glassman; J Hunter-Hayes; T Nakamura
Journal:  West J Med       Date:  1999-10

2.  Accepting commercial sponsorship. Disclosure helps--but is not a panacea.

Authors:  L A Bero
Journal:  BMJ       Date:  1999-09-11

3.  Boundaries in the doctor-patient relationship.

Authors:  Carol Nadelson; Malkah T Notman
Journal:  Theor Med Bioeth       Date:  2002

4.  Are physicians obligated to provide preventive services?

Authors:  D W Belcher
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

5.  The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest.

Authors:  Richard L Allman
Journal:  HEC Forum       Date:  2003-06

6.  The HEC and conflicts of interest in the health care environment.

Authors:  J P Orlowski
Journal:  HEC Forum       Date:  1994-01

7.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

Review 8.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

9.  Response to "Interactions between pharmaceutical representatives and doctors in training: a thematic review".

Authors:  Leana S Wen; Christopher McCoy
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

10.  Is continuing medical education a drug-promotion tool?: YES.

Authors:  Michael A Steinman; Robert B Baron
Journal:  Can Fam Physician       Date:  2007-10       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.